Indrayani Biotech has informed that the Company has been disclosing and will continue to disclose all the material events, information, announcement from time to time that may have bearing on the operations/performance of the Company, including any price sensitive information, as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015. Further clarified that there is no pending material information/announcement to be made as of date which have a bearing on the price/volume movement of the Company or which requires disclosures in accordance with the regulatory requirements.
The above information is a part of company’s filings submitted to BSE.
